Results for tag: "Rebif"

Rebif is a brand of interferon beta-1a, a type of medication used to treat multiple sclerosis (MS). It is a recombinant form of interferon beta-1a, which is a naturally occurring protein in the body that helps regulate the immune system. Rebif is used to reduce the frequency and severity of MS relapses, slow the progression of disability, and reduce the number of lesions seen on MRI scans. It is administered by subcutaneous injection three times a week. Rebif is one of several drugs used to treat MS, including Copaxone, Tecfidera, and Gilenya. These drugs are part of a larger class of medications known as central nervous system drugs, which are used to treat a variety of neurological conditions. Companies in the Rebif market include Merck KGaA, EMD Serono, and Pfizer. Show Less Read more